Vol 2006, No 70 (2006)

Table of Contents

Cartoons

Labelling jpg
Business Review Editor

Deal Trackers

Surfaxin (lucinactant) Abstract pdf
Business Review Editor

Research & Development

Neuromed Pharmaceuticals and Merck Collaborate for Novel Pain Drugs Abstract pdf
Business Review Editor
Exelixis’ and Sankyo’s Cardiovascular Collaboration Abstract pdf
Business Review Editor

Features

Novartis Signs Cancer Deal with Infinite Promise Abstract pdf
Business Review Editor
Myogen's Unpopular Ambrisentan Deal with GSK Abstract pdf
Business Review Editor
Spotlight on Influenza - Separating Fact from Fiction in the Fight against Influenza Abstract pdf
Business Review Editor
Therapy Focus: Tuberculosis Abstract pdf
Business Review Editor

Licensing

Hana Biosciences Licenses Cancer Products from Inex Pharmaceuticals Abstract pdf
Business Review Editor

General

NicOx Upgrades Preclinical Deals Abstract
Business Review Editor
Avidex Ltd Abstract
Business Review Editor

Mergers & Acquisitions

Watson to Acquire Andrx for US$1.9 B Abstract pdf
Business Review Editor

Distribution & Marketing

Celliance and Novo Nordisk Extend Insulin Distribution Alliance Abstract pdf
Business Review Editor

Business Commentaries

The Impact of Clinical Risk Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.